Keith T. Flaherty, Director at Loxo Oncology, Inc. (LOXO), sold 14,390 shares at $45.75 ($649K) on 2017-05-22, disclosed to the SEC on 2017-05-24.
Open-market sale of $649k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.64 | 4,341 | $194K | 29.9% |
| 2 | $44.64 | 4,341 | $194K | 29.9% |
| 3 | $45.75 | 2,799 | $128K | 19.7% |
| 4 | $45.75 | 2,799 | $128K | 19.7% |
| 5 | $46.24 | 110 | $5K | 0.8% |
| Total | $45.08 avg | 14,390 |
| $649K |
| 100% |
| Filing → |
| LOXO | SELL | 2017-08-23 | $775K | — | Filing → |
| LOXO | SELL | 2017-02-23 | $601K | — | Filing → |
| LOXO | SELL | 2016-12-21 | $438K | — | Filing → |